Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 8, 2025
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of …
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
GlobeNewswire
·
May 8, 2025
1Q25 Total Product Revenue of $49.3M FY25 Total Product Revenue Guidance Revised to $250M-$300M FY25 Operating Expenses Reduced and 2H26 Cash Runway Guidance Maintained 2025 Regulatory Approvals for Amtagvi® Expected in the UK, EU, and Canada On Track to …
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial
GlobeNewswire
·
May 8, 2025
GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
GlobeNewswire
·
May 8, 2025
– Generated Q1’25 Quarterly Net Revenue of $177.8 Million, Up 23% Year-over-Year – – Grew Jornay PM® Prescriptions by 24% Year-over-Year and Reported Quarterly Net Revenue of $28.5 Million; Jornay PM Prescribers Reached an All-Time-High – – Completed …
Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
GlobeNewswire
·
May 8, 2025
Topline data from multiple Phase 2 studies expected throughout 2025 • Q2 readout from VTX3232 study in patients with early Parkinson’s disease • H2 readout from VTX2735 study in patients with recurrent pericarditis • H2 readout from VTX3232 study in …
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
SALT LAKE CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter …
Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
Strong execution and progress across pipeline with multiple key data read outs expected in 2025 Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in June Phase 3 barzolvolimab CSU studies enrollment ongoing; Phase 3 program in CIndU …
Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
GlobeNewswire
·
May 8, 2025
Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …
Skye Bioscience Reports First Quarter 2025 Results and Highlights Nimacimab Differentiation in Obesity
GlobeNewswire
·
May 8, 2025
Nimacimab in combination with tirzepatide improves weight loss effect over tirzepatide alone, and shows comparable weight loss to monlunabant and tirzepatide alone in preclinical diet-induced obesity model In vitro data reported from new preclinical study …
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 8, 2025
Interim analysis from the TX45 Phase 1b Part A trial demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH- …
Christian Howard offers facts to support Einstein’s statement "reality is merely an illusion".
EIN Presswire
·
May 8, 2025
NEWPORT BEACH, CA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- When asked to explain about the world being an illusion, Howard replies: “Like Einstein, millions of people believe the physical world is an illusion. Thousands of events prove …
Pacira BioSciences Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
-- Conference call today at 4:30 p.m. ET -- BRISBANE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of …
Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress
GlobeNewswire
·
May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three Late Breaking Science presentations and one ePoster presentation at Heart Failure 2025, an International Congress of the European …
Mattermost and Qrypt Announce Joint Development Program for Quantum Secure End-to-End Encryption Collaboration Platform
GlobeNewswire
·
May 8, 2025
Baltimore, MD, May 08, 2025 (GLOBE NEWSWIRE) -- Mattermost, the leading provider of secure collaboration and workflow for sensitive data environments, and Qrypt, a pioneer in quantum-secure encryption, today announced a Joint Development Program to deliver …
Canyon GBS Joins EDUCAUSE Webinar to Spotlight Practical, Compliant AI for Colleges and Universities
GlobeNewswire
·
May 8, 2025
Scottsdale, Arizona, May 08, 2025 (GLOBE NEWSWIRE) -- Canyon GBS, a leader in AI-powered SaaS solutions for higher education, has announced its participation in an EDUCAUSE Industry Insights webinar titled “Unlocking AI’s Potential in Higher Ed” on Tuesday …
MEDIAIPLUS leads data-driven solutions to close clinical trial information gaps
EIN Presswire
·
May 8, 2025
MEDIAIPLUS uses AI to close clinical trial info gaps, offering data tools that match CROs, aid researchers, and support global pharma with smart solutions. PANGYO, GYEONGGI-DO, SOUTH KOREA, May 8, 2025 /EINPresswire.com/ -- Founded in 2019, MEDIAIPLUS …
Ovul launches innovative estrogen trend indicator for enhanced hormonal wellness and menopause support
EIN Presswire
·
May 8, 2025
MINNETONKA, MN, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Ovul, a leading innovator in women’s health technology, today announced a groundbreaking new feature available on its iOS app: the Estrogen Trend Indicator. This innovative feature expands …
Kajeet Urges House to Support Schools and Libraries Counting on E-Rate Funding for Hotspots
GlobeNewswire
·
May 8, 2025
MCLEAN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Following today’s Congressional Review Act (CRA) block of the Federal Communications Commission Wi-Fi hotspots order, which removes E-Rate funding eligibility for these devices, Kajeet®, a leading provider of …
Merus participera à la conférence BofA Securities 2025 sur les soins de santé
GlobeNewswire
·
May 8, 2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachussets, 08 mai 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise spécialisée en oncologie développant des anticorps de pleine longueur multispécifiques (Biclonics® et Triclonics®), a annoncé …
Merus hält einen Vortrag auf der BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 8, 2025
UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, May 08, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Onkologieunternehmen, das innovative, multispezifische Antikörper in voller Länge (Biclonics® und Triclonics®) entwickelt, hat heute …